Oxbow Advisors, LLC Merck & Co., Inc. Transaction History

Oxbow Advisors, LLC

$891 Million
Q3 2024

A detailed history of Oxbow Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Oxbow Advisors, LLC holds 49,278 shares of MRK stock, worth $4.83 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

49,278

Previous 23,442 110.21%

Holding current value

$4.83 Million

Previous $2.9 Million 92.83%

% of portfolio

0.63%

Previous 0.39%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$111.15 - $128.97 $2.87 Million - $3.33 Million	25,836 Added 110.21%	49,278 $5.6 Million
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $2.32 Million - $2.49 Million	18,710 Added 395.39%	23,442 $2.9 Million
Q1 2024 May 06, 2024	SELL	$113.24 - $131.95 $335,416 - $390,835	-2,962 Reduced 38.5%	4,732 $624,000
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $1,703 - $1,853	17 Added 0.22%	7,694 $838,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $478,820 - $531,748	-4,651 Reduced 37.73%	7,677 $790,000
Q2 2023 Aug 04, 2023	BUY	$108.61 - $118.38 $241,657 - $263,395	2,225 Added 22.02%	12,328 $1.42 Million
Q1 2023 Apr 25, 2023	SELL	$102.94 - $114.86 $106,645 - $118,994	-1,036 Reduced 9.3%	10,103 $1.07 Million
Q4 2022 Feb 01, 2023	BUY	$87.44 - $112.11 $124,077 - $159,084	1,419 Added 14.6%	11,139 $1.24 Million
Q3 2022 Nov 03, 2022	SELL	$84.53 - $94.96 $23,837 - $26,778	-282 Reduced 2.82%	9,720 $837,000
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $478,982 - $542,949	5,737 Added 134.51%	10,002 $912,000
Q1 2022 May 09, 2022	SELL	$73.51 - $82.4 $8.81 Million - $9.88 Million	-119,887 Reduced 96.56%	4,265 $350,000
Q4 2021 Feb 09, 2022	SELL	$72.28 - $90.54 $82,832 - $103,758	-1,146 Reduced 0.91%	124,152 $9.52 Million
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $72,396 - $79,618	1,010 Added 0.81%	125,298 $9.41 Million
Q2 2021 Aug 04, 2021	BUY	$70.31 - $77.77 $325,746 - $360,308	4,633 Added 3.87%	124,288 $9.67 Million
Q1 2021 May 11, 2021	BUY	$68.86 - $81.11 $56,189 - $66,185	816 Added 0.69%	119,655 $9.22 Million
Q4 2020 Feb 02, 2021	SELL	$71.77 - $79.65 $139,090 - $154,361	-1,938 Reduced 1.6%	118,839 $9.72 Million
Q3 2020 Nov 06, 2020	BUY	$73.18 - $82.95 $4.26 Million - $4.83 Million	58,214 Added 93.05%	120,777 $10 Million
Q2 2020 Aug 12, 2020	BUY	$70.42 - $80.13 $4 Million - $4.55 Million	56,748 Added 975.89%	62,563 $4.84 Million
Q1 2020 May 06, 2020	SELL	$63.36 - $87.82 $72,293 - $100,202	-1,141 Reduced 16.4%	5,815 $447,000
Q4 2019 Feb 06, 2020	BUY	$77.58 - $87.54 $63,615 - $71,782	820 Added 13.36%	6,956 $633,000
Q3 2019 Oct 31, 2019	BUY	$76.08 - $82.93 $8,140 - $8,873	107 Added 1.77%	6,136 $517,000
Q2 2019 Aug 07, 2019	SELL	$69.84 - $81.59 $167,616 - $195,816	-2,400 Reduced 28.47%	6,029 $506,000
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $20,224 - $23,470	-310 Reduced 3.55%	8,429 $644,000
Q3 2018 Nov 06, 2018	SELL	$57.69 - $67.84 $110,764 - $130,252	-1,920 Reduced 18.01%	8,739 $620,000
Q1 2018 Apr 30, 2018	SELL	$50.96 - $59.23 $17,937 - $20,848	-352 Reduced 3.2%	10,659 $581,000
Q4 2017 Jan 30, 2018	SELL	$51.62 - $61.64 $20,596 - $24,594	-399 Reduced 3.5%	11,011 $620,000
Q3 2017 Oct 23, 2017	BUY	$58.67 - $63.13 $669,424 - $720,313	11,410	11,410 $731,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oxbow Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oxbow Advisors, LLC with notifications on news.

Account

Oxbow Advisors, LLC Merck & Co., Inc. Transaction History